20 related articles for article (PubMed ID: 22365911)
1. Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice.
Bird SM; Bailey RA; Grieve AP; Senn S
Pharm Stat; 2017 Mar; 16(2):100-106. PubMed ID: 28206702
[TBL] [Abstract][Full Text] [Related]
2. Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease.
Zhao J; Zhao Y; Hu Y; Peng J
Cell Mol Biol Lett; 2021 Jul; 26(1):32. PubMed ID: 34233623
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.
Negoro K; Yonetoku Y; Misawa-Mukai H; Hamaguchi W; Maruyama T; Yoshida S; Takeuchi M; Ohta M
Bioorg Med Chem; 2012 Sep; 20(17):5235-46. PubMed ID: 22836190
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
Negoro K; Yonetoku Y; Moritomo A; Hayakawa M; Iikubo K; Yoshida S; Takeuchi M; Ohta M
Bioorg Med Chem; 2012 Nov; 20(21):6442-51. PubMed ID: 23010456
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines as orally available G protein-coupled receptor 119 agonists.
Katamreddy SR; Carpenter AJ; Ammala CE; Boros EE; Brashear RL; Briscoe CP; Bullard SR; Caldwell RD; Conlee CR; Croom DK; Hart SM; Heyer DO; Johnson PR; Kashatus JA; Minick DJ; Peckham GE; Ross SA; Roller SG; Samano VA; Sauls HR; Tadepalli SM; Thompson JB; Xu Y; Way JM
J Med Chem; 2012 Dec; 55(24):10972-94. PubMed ID: 23214471
[TBL] [Abstract][Full Text] [Related]
6. Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.
Gillespie P; Goodnow RA; Saha G; Bose G; Moulik K; Zwingelstein C; Myers M; Conde-Knape K; Pietranico-Cole S; So SS
Bioorg Med Chem Lett; 2014 Feb; 24(3):949-53. PubMed ID: 24412066
[TBL] [Abstract][Full Text] [Related]
7. 2,5-Disubstituted pyridines as potent GPR119 agonists.
Wu Y; Kuntz JD; Carpenter AJ; Fang J; Sauls HR; Gomez DJ; Ammala C; Xu Y; Hart S; Tadepalli S
Bioorg Med Chem Lett; 2010 Apr; 20(8):2577-81. PubMed ID: 20227877
[TBL] [Abstract][Full Text] [Related]
8. One hundred years of Meldrum's acid: advances in the synthesis of pyridine and pyrimidine derivatives.
Lipson VV; Gorobets NY
Mol Divers; 2009 Nov; 13(4):399-419. PubMed ID: 19381852
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists.
Negoro K; Yonetoku Y; Maruyama T; Yoshida S; Takeuchi M; Ohta M
Bioorg Med Chem; 2012 Apr; 20(7):2369-75. PubMed ID: 22365911
[TBL] [Abstract][Full Text] [Related]
10. G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges.
Ritter K; Buning C; Halland N; Pöverlein C; Schwink L
J Med Chem; 2016 Apr; 59(8):3579-92. PubMed ID: 26512410
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
